« Back to Record
Carey, L. L., Loirat, D., Punie, K., Bardia, A., Diéras, V., Dalenc, F., Diamond, J. J., Fontaine, C., Wang, G., Rugo, H. H., Hurvitz, S., Kalinsky, K., O'Shaughnessy, J., Loibl, S., Gianni, L., Piccart-Gebhart, M., Zhu, Y., Delaney, R., Phan, S., & Cortes, J. (2022). Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis. NPJ breast cancer, 8(1), 72. doi:10.1038/s41523-022-00439-5
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/350453



